Kgs. Lyngby, Denmark

Mads Agervig Tarp


 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Lyngby, DK (2013)
  • Kgs. Lyngby, DK (2014 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mads Agervig Tarp: Innovator in Cancer Immunotherapy

Introduction

Mads Agervig Tarp is an esteemed inventor based in Kgs. Lyngby, Denmark, recognized for his significant contributions to the field of cancer research and immunotherapy. With a total of five patents to his name, Tarp is at the forefront of developing innovative methods for inducing cancer-specific immune responses.

Latest Patents

Among his latest innovations is a groundbreaking patent titled "Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies." This invention provides a method for inducing a cancer-specific immune response against MUC1 using an immunogenic glycopeptide. The scope of this patent extends to include a pharmaceutical composition that incorporates the immunogenic glycopeptide, as well as a cancer vaccine designed for therapeutic applications. Additionally, the patent encompasses antibodies generated through the use of the immunogenic glycopeptide, aimed at applications in both therapy and diagnosis.

Career Highlights

Mads Agervig Tarp has built a distinguished career working with notable organizations such as Cancer Research Technology Limited and Københavns Universitet. His work in these institutions has enabled him to focus on innovative approaches to cancer treatment and immunological research, contributing valuable insights to the scientific community.

Collaborations

Throughout his career, Tarp has collaborated with prominent professionals in the field, including Henrik Clausen and Joy Burchell. These collaborations have further developed his research and innovations, allowing for the integration of diverse expertise that enhances the impact of his work.

Conclusion

Mads Agervig Tarp's contributions to the field of cancer immunotherapy are marked by his innovative patents and collaborative efforts. His ongoing work continues to push the boundaries of cancer treatment, aiming to provide new hope for patients and advancing the scientific understanding of immune responses in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…